Search research articles
Contact Us
Filters
Showing results (851-860 of 932) with videos related to
Page
of 94
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 18, 2022
Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984
Joseph W Kim, Rana R McKay, Marc R Radke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 2023
Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
Justin Hwang, Xiaolei Shi, Andrew Elliott, et al.
JAMA Network Open
|
September 18, 2023
Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer
Clara Hwang, Nicholas C Henderson, Shih-Chun Chu, et al.
Cancer Immunology Research
|
June 6, 2023
Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma
Renee Maria Saliby, Talal El Zarif, Ziad Bakouny, et al.
Immunity
|
April 3, 2026
Distinct tissue niches contribute to prostate tissue-resident memory CD8<sup>+</sup> T cell differentiation and heterogeneity
Kennidy K Takehara, Alexander Monell, Vida Luna, et al.
The New England Journal of Medicine
|
July 1, 2026
Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma
Toni K Choueiri, Robert J Motzer, Jose A Karam, et al.
JCO Precision Oncology
|
December 5, 2025
Impact of <i>SPOP</i> Mutations on Clinical Outcomes in Metastatic Prostate Cancer
Deepak Kilari, Nicholas C Henderson, Kyra Yamamoto, et al.
JAMA Network Open
|
April 15, 2026
Clinical and Molecular Validation of the Very Favorable IMDC Risk Group in Metastatic Renal Cell Carcinoma
Martin Zarba, Eddy Saad, Karl Semaan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2021
Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer
Jamie M Sperger, Hamid Emamekhoo, Rana R McKay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 27, 2023
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer
Peter H O'Donnell, Matthew I Milowsky, Daniel P Petrylak, et al.
Page
of 94
Search research articles
Search
Showing results (851-860 of 932) with videos related to
Sort By:
Page
of 94
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 18, 2022
Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984
Joseph W Kim, Rana R McKay, Marc R Radke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 2023
Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
Justin Hwang, Xiaolei Shi, Andrew Elliott, et al.
JAMA Network Open
|
September 18, 2023
Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer
Clara Hwang, Nicholas C Henderson, Shih-Chun Chu, et al.
Cancer Immunology Research
|
June 6, 2023
Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma
Renee Maria Saliby, Talal El Zarif, Ziad Bakouny, et al.
Immunity
|
April 3, 2026
Distinct tissue niches contribute to prostate tissue-resident memory CD8<sup>+</sup> T cell differentiation and heterogeneity
Kennidy K Takehara, Alexander Monell, Vida Luna, et al.
The New England Journal of Medicine
|
July 1, 2026
Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma
Toni K Choueiri, Robert J Motzer, Jose A Karam, et al.
JCO Precision Oncology
|
December 5, 2025
Impact of <i>SPOP</i> Mutations on Clinical Outcomes in Metastatic Prostate Cancer
Deepak Kilari, Nicholas C Henderson, Kyra Yamamoto, et al.
JAMA Network Open
|
April 15, 2026
Clinical and Molecular Validation of the Very Favorable IMDC Risk Group in Metastatic Renal Cell Carcinoma
Martin Zarba, Eddy Saad, Karl Semaan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 2021
Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer
Jamie M Sperger, Hamid Emamekhoo, Rana R McKay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 27, 2023
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer
Peter H O'Donnell, Matthew I Milowsky, Daniel P Petrylak, et al.
Page
of 94